MOESM2 of Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma

Zimmer, Lisa; Eigentler, Thomas; Kiecker, Felix; Simon, Jan; Utikal, Jochen; Mohr, Peter; Berking, Carola; KĂ¤mpgen, Eckhart; Dippel, Edgar; Stadler, Rudolf; Hauschild, Axel; Fluck, Michael; Terheyden, Patrick; Rompel, Rainer; Loquai, Carmen; Assi, Zeinab; Garbe, Claus; Schadendorf, Dirk

doi:10.6084/m9.figshare.c.3618377_D4.v1

12967_2015_716_MOESM2_ESM.pdf (1.34 MB)

MOESM2 of Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma

journal contribution

posted on 2015-11-06, 05:00 authored by Lisa Zimmer, Thomas Eigentler, Felix Kiecker, Jan Simon, Jochen Utikal, Peter Mohr, Carola Berking, Eckhart KĂ¤mpgen, Edgar Dippel, Rudolf Stadler, Axel Hauschild, Michael Fluck, Patrick Terheyden, Rainer Rompel, Carmen Loquai, Zeinab Assi, Claus Garbe, Dirk Schadendorf

Additional file 2. Protocol DeCOG âMM-PAL11-Trial.